Table 5.

Progressive motility (%)

Group	Class	Statistics	Placebo	Supplementation	p‐value
With varicocele	Age < 35	N	13	18	.5159
		Mean	2.16	4.18
		Std. Dev.	7.1	9.28
Without varicocele	Age < 35	N	18	16	.3979
		Mean	4.11	7.71
		Std. Dev.	9.35	14.84
With varicocele	Age ≥ 35	N	13	8	.3628
		Mean	1.58	4.1
		Std. Dev.	6.28	5.54
Without varicocele	Age ≥ 35	N	8	10	.0831
		Mean	−5.15	3.52
		Std. Dev.	11.14	8.79
With varicocele	BMI < 25	N	19	20	.0159
		Mean	0.87	5.93
		Std. Dev.	4.48	7.55
Without varicocele	BMI < 25	N	22	21	.1905
		Mean	1.85	6.69
		Std. Dev.	9.67	13.89
With varicocele	BMI ≥ 25	N	7	6	.2524
		Mean	4.57	−1.75
		Std. Dev.	10.4	8.06
Without varicocele	BMI ≥ 25	N	4	5	.5133
		Mean	−1.95	3.64
		Std. Dev.	16.5	7.22
With varicocele	Age < 35 & BMI < 25	N	10	13	.0599
		Mean	−0.12	6.12
		Std. Dev.	4.5	9.07
Without varicocele	Age < 35 & BMI < 25	N	15	13	.3311
		Mean	4.12	8.94
		Std. Dev.	8.88	16.28